Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei-Lin Xu

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Zhonghua Nei Ke Za Zhi|August 14, 2012
[Quantitative monitoring of blood cytomegalovirus after allogeneic hematopoietic stem cell transplantation and its clinical significance]Zhi-Xiang Qiu, Mang-Ju Wang, Li-Hong Wang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 25, 2009
[Effect of graft-versus-host disease on relapse and survival in 100 patients after allogeneic hematopoietic stem cell transplantation]Xue-Rong Deng, Han-Yun Ren, Xi-Nan Cen, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 21, 2010
[Incidence and risk factors of hemorrhagic cystitis after hematopoietic stem cell transplantation]Xiang-Juan Ma, Han-Yun Ren, Zhi-Xiang Qiu, et al.
Frontiers in Immunology|March 14, 2022
Low-Dose 5-Aza and DZnep Alleviate Acute Graft-<i>Versus</i>-Host Disease With Less Side Effects Through Altering T-Cell DifferentiationQing Ya Wang, Hui Hui Liu, Yu Jun Dong, et al.
Zhonghua Yi Xue Za Zhi|February 12, 2008
[Candida species distribution in the patients with high risk of deep fungal infections and relevant risk factors: a prospective cohort study]Jin Yu, Min Zhang, Jian-Lei Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 13, 2011
[Application of SPECT/PET to 70 patients with lymphoma: monitoring response to therapy]Hui Yao, Xi-Nan Cen, Ze-Yin Liang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 28, 2017
[Salvage Trerapy for Patients with Relapsed and Refractory Lymphoma by Allogeneic Hematopoietic Stem Cell Transplantation]Yue Yin, Zhi-Xiang Qiu, Yuan Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 23, 2010
[Quantitative monitoring of mononucleated cell Epstein-Barr virus (EBV)-DNA for predicting EBV associated lymphoproliferative disorders after stem cell transplantation.]Li-Hong Wang, Han-Yun Ren, Yu-Hua Sun, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 15, 2013
[Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation]Ze-Yin Liang, Han-Yun Ren, Xi-Nan Cen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 23, 2013
[Hematopoietic reconstitution on the prognosis of hematological malignancies after allogeneic hematopoietic stem cell transplantation]Yan Zhang, Han-Yun Ren, Zhi-Xiang Qiu, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Zhonghua Nei Ke Za Zhi|August 14, 2012
[Quantitative monitoring of blood cytomegalovirus after allogeneic hematopoietic stem cell transplantation and its clinical significance]Zhi-Xiang Qiu, Mang-Ju Wang, Li-Hong Wang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 25, 2009
[Effect of graft-versus-host disease on relapse and survival in 100 patients after allogeneic hematopoietic stem cell transplantation]Xue-Rong Deng, Han-Yun Ren, Xi-Nan Cen, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 21, 2010
[Incidence and risk factors of hemorrhagic cystitis after hematopoietic stem cell transplantation]Xiang-Juan Ma, Han-Yun Ren, Zhi-Xiang Qiu, et al.
Frontiers in Immunology|March 14, 2022
Low-Dose 5-Aza and DZnep Alleviate Acute Graft-<i>Versus</i>-Host Disease With Less Side Effects Through Altering T-Cell DifferentiationQing Ya Wang, Hui Hui Liu, Yu Jun Dong, et al.
Zhonghua Yi Xue Za Zhi|February 12, 2008
[Candida species distribution in the patients with high risk of deep fungal infections and relevant risk factors: a prospective cohort study]Jin Yu, Min Zhang, Jian-Lei Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 13, 2011
[Application of SPECT/PET to 70 patients with lymphoma: monitoring response to therapy]Hui Yao, Xi-Nan Cen, Ze-Yin Liang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 28, 2017
[Salvage Trerapy for Patients with Relapsed and Refractory Lymphoma by Allogeneic Hematopoietic Stem Cell Transplantation]Yue Yin, Zhi-Xiang Qiu, Yuan Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 23, 2010
[Quantitative monitoring of mononucleated cell Epstein-Barr virus (EBV)-DNA for predicting EBV associated lymphoproliferative disorders after stem cell transplantation.]Li-Hong Wang, Han-Yun Ren, Yu-Hua Sun, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 15, 2013
[Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation]Ze-Yin Liang, Han-Yun Ren, Xi-Nan Cen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 23, 2013
[Hematopoietic reconstitution on the prognosis of hematological malignancies after allogeneic hematopoietic stem cell transplantation]Yan Zhang, Han-Yun Ren, Zhi-Xiang Qiu, et al.
Pageof 5